Clozapine for the Treatment of Adolescents with Schizophrenia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (20)
Clozapine for the Treatment-Resistant Schizophrenic
1988 • 4,030 citations
Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
1983 • 680 citations
The Risks and Benefits of Clozapine versus Chlorpromazine
1987 • 299 citations
Tolerability and therapeutic effect of clozapine
1985 • 277 citations
The effect of long‐term treatment with clozapine in schizophrenia: A retrospective study in 96 patients treated with clozapine for up to 13 years
1988 • 249 citations
Clozapine: guidelines for clinical management.
1989 • 230 citations
Tardive dyskinesia: review and update
1980 • 210 citations
CLOZAPINE AND HALOPERIDOL IN A SINGLE‐BLIND CROSS‐OVER TRIAL: THERAPEUTIC AND BIOCHEMICAL ASPECTS IN THE TREATMENT OF SCHIZOPHRENIA
1974 • 198 citations
Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
1987 • 119 citations
Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents
1984 • 103 citations
Tardive Dyskinesia: Research and Treatment
1981 • 102 citations
Psychiatric Adolescent Inpatients
1979 • 102 citations
Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage
1990 • 96 citations
Neuroleptic-Induced Dyskinesias in Children
1983 • 95 citations
Diagnosis and Psychopharmacology of Childhood and Adolescent Disorders
1986 • 95 citations
Clinical and epidemiologic aspects of tardive dyskinesia.
1985 • 72 citations
Tardive Dyskinesia: Research & Treatment
2012 • 70 citations
Diagnosis and psychopharmacology of childhood and adolescent disorders
1985 • 61 citations
Clozapine effects on tardive dyskinesia.
1989 • 43 citations
Clozapine in the Treatment of Tardive Dyskinesia: an Interim Report
1980 • 40 citations